The Eureka Medical Laboratories says that it is capable of testing for and detecting new strains of the novel coronavirus (COVID-19) which have been seen in different parts of the world.
In a press release yesterday, the laboratory said some of the variants include one which was first identified in the United Kingdom which is knows as SARS-CoV2 VUI 202012/01. According to the press release this was identified through viral genomic sequencing and is identified by multiple spike protein mutations.